Skip to main content
. 2015 Jan 15;8(1):876–882.

Table 1.

General characteristics and treatment modalities of patients

Total number of patients 30
Gender
    Female 50%
    Male 50%
Stage
    Stage 1-b 16.7%
    Stage 2-a 30%
    Stage 3 53.3%
Histopathology
    Adenocarcinoma 86.7%
    Squamous cell carcinoma 13.3%
    CT regimen
    5-FU 20%
    FUFA (5-FU, Folinic Acid) 33.3%
    Mac Donald 16.7%
    DCF (Docetaxel, 5-FU, Cisplatin) 3.3%
    Cisplatin 26.5%
Mean RT dose 46.5 Gy
Duration of follow-up 3 months

RT: Radiotherapy, CT: Chemotherapy, 5-FU: 5-Fluorouracil.